A detailed history of Van Eck Associates Corp transactions in United Therapeutics Corp stock. As of the latest transaction made, Van Eck Associates Corp holds 10,756 shares of UTHR stock, worth $3.87 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,756
Previous 10,894 1.27%
Holding current value
$3.87 Million
Previous $3.47 Million 9.28%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

SELL
$311.04 - $363.55 $42,923 - $50,169
-138 Reduced 1.27%
10,756 $3.79 Million
Q2 2024

Jul 31, 2024

BUY
$228.26 - $319.04 $81,032 - $113,259
355 Added 3.37%
10,894 $3.47 Million
Q1 2024

Apr 30, 2024

BUY
$210.76 - $249.51 $100,111 - $118,517
475 Added 4.72%
10,539 $2.42 Million
Q4 2023

Feb 05, 2024

BUY
$214.88 - $256.94 $81,439 - $97,380
379 Added 3.91%
10,064 $2.21 Million
Q3 2023

Nov 08, 2023

BUY
$211.82 - $248.24 $17,792 - $20,852
84 Added 0.87%
9,685 $2.19 Million
Q2 2023

Aug 03, 2023

BUY
$205.19 - $232.99 $1.11 Million - $1.26 Million
5,419 Added 129.58%
9,601 $2.12 Million
Q1 2023

May 03, 2023

BUY
$212.99 - $276.17 $562,719 - $729,641
2,642 Added 171.56%
4,182 $937,000
Q4 2022

Feb 08, 2023

BUY
$205.95 - $280.43 $42,837 - $58,329
208 Added 15.62%
1,540 $428,000
Q3 2022

Oct 27, 2022

BUY
$203.3 - $244.17 $24,396 - $29,300
120 Added 9.9%
1,332 $279,000
Q2 2022

Aug 03, 2022

BUY
$174.81 - $241.14 $23,774 - $32,795
136 Added 12.64%
1,212 $286,000
Q1 2022

May 10, 2022

BUY
$166.16 - $213.96 $24,591 - $31,666
148 Added 15.95%
1,076 $193,000
Q4 2021

Jan 26, 2022

BUY
$184.32 - $216.08 $7,925 - $9,291
43 Added 4.86%
928 $201,000
Q3 2021

Nov 03, 2021

SELL
$179.86 - $214.88 $683,647 - $816,758
-3,801 Reduced 81.11%
885 $163,000
Q2 2021

Aug 10, 2021

BUY
$170.47 - $211.93 $79,609 - $98,971
467 Added 11.07%
4,686 $841,000
Q1 2021

May 13, 2021

BUY
$153.94 - $174.85 $649,472 - $737,692
4,219 New
4,219 $706,000
Q3 2020

Nov 12, 2020

SELL
$99.9 - $121.13 $5.81 Million - $7.05 Million
-58,177 Closed
0 $0
Q2 2020

Aug 10, 2020

BUY
$92.74 - $125.82 $740,528 - $1 Million
7,985 Added 15.91%
58,177 $7.04 Million
Q1 2020

May 12, 2020

SELL
$79.39 - $115.35 $283,978 - $412,606
-3,577 Reduced 6.65%
50,192 $4.76 Million
Q4 2019

Feb 13, 2020

BUY
$78.31 - $95.34 $386,303 - $470,312
4,933 Added 10.1%
53,769 $4.74 Million
Q3 2019

Nov 08, 2019

SELL
$74.85 - $85.99 $412,573 - $473,976
-5,512 Reduced 10.14%
48,836 $3.9 Million
Q2 2019

Aug 07, 2019

SELL
$76.06 - $120.81 $1.42 Million - $2.26 Million
-18,676 Reduced 25.58%
54,348 $4.24 Million
Q1 2019

May 13, 2019

SELL
$107.15 - $126.84 $953,635 - $1.13 Million
-8,900 Reduced 10.86%
73,024 $8.57 Million
Q4 2018

Feb 12, 2019

SELL
$101.4 - $128.73 $74,529 - $94,616
-735 Reduced 0.89%
81,924 $8.92 Million
Q3 2018

Nov 13, 2018

BUY
$113.81 - $129.46 $155,578 - $176,971
1,367 Added 1.68%
82,659 $10.6 Million
Q2 2018

Aug 13, 2018

BUY
$101.14 - $118.31 $1.74 Million - $2.04 Million
17,203 Added 26.84%
81,292 $9.2 Million
Q1 2018

May 11, 2018

SELL
$107.21 - $151.94 $1.64 Million - $2.32 Million
-15,294 Reduced 19.27%
64,089 $7.2 Million
Q4 2017

Feb 12, 2018

SELL
$118.58 - $151.28 $5.18 Million - $6.61 Million
-43,717 Reduced 35.51%
79,383 $11.7 Million
Q3 2017

Nov 09, 2017

BUY
$114.6 - $136.81 $1.21 Million - $1.45 Million
10,598 Added 9.42%
123,100 $14.4 Million
Q2 2017

Aug 11, 2017

BUY
N/A
112,502
112,502 $14.6 Million

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.4B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Van Eck Associates Corp Portfolio

Follow Van Eck Associates Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Van Eck Associates Corp, based on Form 13F filings with the SEC.

News

Stay updated on Van Eck Associates Corp with notifications on news.